Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

High-grade epithelial ovarian cancer (HGEOC) is a clinically diverse and molecularly heterogeneous disease comprising subtypes with distinct biological features and outcomes. The receptor tyrosine kinases, expressed by EOC cells, and their ligands, present in the microenvironment, activate signaling...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Rea, Katia, Pinciroli, Patrizia, Sensi, Marialuisa, Alciato, Federica, Bisaro, Brigitte, Lozneanu, Ludmila, Raspagliesi, Francesco, Centritto, Floriana, Cabodi, Sara, Defilippi, Paola, Avanzi, Gian Carlo, Canevari, Silvana, Tomassetti, Antonella
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741573/
https://ncbi.nlm.nih.gov/pubmed/26356564
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia